Agree - anxious to hear her results. Another ve
Post# of 157604

Another very interesting point: insurance approval for Keytruda. Does this mean they not only understand but also value the correlation between CCR5, PD-L1, etc.? If so, isn't that good news for CYDY? I wonder if her insurer is one of the big ones like UHC.

